RadNet (NASDAQ:RDNT - Get Free Report) is anticipated to issue its quarterly earnings data before the market opens on Friday, February 28th. Analysts expect the company to announce earnings of $0.21 per share and revenue of $459.42 million for the quarter. Parties that wish to listen to the company's conference call can do so using this link.
RadNet Trading Down 5.1 %
NASDAQ:RDNT traded down $3.20 during trading hours on Friday, hitting $59.47. The company had a trading volume of 1,024,560 shares, compared to its average volume of 790,519. The company has a debt-to-equity ratio of 0.89, a current ratio of 2.16 and a quick ratio of 2.16. The stock has a 50-day moving average price of $67.00 and a 200 day moving average price of $69.07. The company has a market capitalization of $4.40 billion, a PE ratio of -849.45 and a beta of 1.79. RadNet has a 52 week low of $36.47 and a 52 week high of $93.65.
Insider Activity
In related news, EVP David Jeffrey Katz sold 12,300 shares of the company's stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $81.65, for a total value of $1,004,295.00. Following the sale, the executive vice president now owns 62,909 shares in the company, valued at $5,136,519.85. This represents a 16.35 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Company insiders own 5.12% of the company's stock.
Analysts Set New Price Targets
A number of equities research analysts have recently weighed in on RDNT shares. Barclays cut their target price on shares of RadNet from $85.00 to $74.00 and set an "overweight" rating on the stock in a research note on Wednesday, January 22nd. Truist Financial reiterated a "buy" rating and set a $88.00 target price (down previously from $94.00) on shares of RadNet in a report on Wednesday, January 22nd. Finally, Jefferies Financial Group dropped their price target on RadNet from $100.00 to $80.00 and set a "buy" rating on the stock in a research report on Wednesday, January 15th. One investment analyst has rated the stock with a sell rating, four have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $75.50.
Check Out Our Latest Analysis on RDNT
RadNet Company Profile
(
Get Free Report)
RadNet, Inc, together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.
Featured Articles

Before you consider RadNet, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RadNet wasn't on the list.
While RadNet currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.